Hi Ruxandra, an anti-aging biotech is already testing an immune therapy for sarcopenia and muscle loss. Its in Phase 1 trials and Phase 2A https://immunisbiomedical.com/pipeline/
Immunology is beyond my understanding, but your recent series makes me think about evidence (weak in humans but good in some other species) that rapamycin may slow aging and increase life expectancy. The drug is usually considered an immune suppressant, though unsurprisingly (considering the baroque nature of the immune system) in low doses it may enhance immune surveillance.
Hi Ruxandra, an anti-aging biotech is already testing an immune therapy for sarcopenia and muscle loss. Its in Phase 1 trials and Phase 2A https://immunisbiomedical.com/pipeline/
Immunology is beyond my understanding, but your recent series makes me think about evidence (weak in humans but good in some other species) that rapamycin may slow aging and increase life expectancy. The drug is usually considered an immune suppressant, though unsurprisingly (considering the baroque nature of the immune system) in low doses it may enhance immune surveillance.